Discovery/development of gaba-a ?5 positive allosteric modulators for treatment of MCI due to ad

Ended Cooperative Agreement Awarded Last action

Award ID
UH3NS101856
Recipient
Awarding agency
Obligated
$1,005,197

Award facts

Assistance listing
93.866 Aging Research
Completion date
Originally
Funding
  • $1,005,196.00 Federal
  • $1.00 Non-federal
Funding agency
National Institute on Aging National Institutes of Health, Department of Health and Human Services
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1 $0
Amendment $1 $1
Amendment $0 $0
Amendment $134,923 $0
Amendment $206,281 $0
Amendment $12,312 $0
Original award $651,678 $0
Show all 16

Quick answers

Who received award UH3NS101856?

UH3NS101856 was awarded to Agenebio, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 15, 2017.

How much is award UH3NS101856 worth?

$1,005,197 has been obligated on UH3NS101856: $1,005,196 in federal funding and $1 in non-federal funding.

Which agency awarded UH3NS101856?

National Institute of Neurological Disorders and Stroke (National Institutes of Health) awarded UH3NS101856, with funding from National Institute on Aging (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award